What is Uveitis?

Uveitis refers to inflammation inside the eye. This post reviews the symptoms, causes and treatment options.
The post What is Uveitis? appeared first on Retina Specialist | Fairfax, Virginia | Retinal Diseases.

Do You Have Dry Eye?

Did you know that tearing is actually a common symptom of dry eye? Here’s a review of the symptoms and causes of dry eye.
The post Do You Have Dry Eye? appeared first on Retina Specialist | Fairfax, Virginia | Retinal Diseases.

Happy Thanksgiving 2016

Here’s what we are doing for Thanksgiving. We are frying a turkey. What about you? I’ve also have so high hopes for this website!
The post Happy Thanksgiving 2016 appeared first on Retina Specialist | Fairfax, Virginia | Retinal Diseases.

Articles Published in Ophthalmic Journals in 2015

In addition to the several updates posted on this blog in 2015 (see previous posting), I have prepared four articles that have appeared in ophthalmic journals this year.

Here is a brief summary of the four articles, including links to the online versions:
Regenerating the Retina – February 2015
This article, published in the February 2015 issue of The Ophthalmologist, describes the use of stem cell-derived retinal progenitor cells (RPCs), that are being investigated for reviving/repairing/rejuvenating damaged photoreceptors to bring back sight to those who have lost it due to a retinal degenerative disease, including choroideremeia (CHM), retinitis pigmentosa (Read more...)

Blog Articles Published in 2015

2015 was another busy year in writing about new developments in treating retinal diseases. During the year, I published seven blog entries (and another four published articles – to be indexed separately). Here are the highlights of the blog writeups:
Since I last wrote about Iluvien, Alimera Sciences and pSivida have announced additional marketing approvals for its use in treating chronic DME. The product is now approved for use in fourteen countries, including the U.S. In addition, pSivida is about to (Read more...)

Oraya IRay Update 4: Oraya Therapeutics Receives Guidance for Use in Germany

When I last updated the progress of Oraya Therapeutics, in January of this year (Oraya IRay Update 3: Oraya Now Operating at Nine European Centers and Partnership with Carl Zeiss Meditec), I noted the collaboration agreement between Oraya and Carl Zeiss Meditec to provide funding to Oraya over a period of up to two years for the implementation of Oraya’s growth strategy, and I reported on the three-year INTREPID safety results, presented the previous September. Here now is the latest information on the progress of the company to bring this adjunctive treatment for the wet form of AMD (Read more...)

Gene Therapy in Ophthalmology Update 22: First Spark Therapeutic Phase III Clinical Trial Results and Phase I Longevity Data

My article updating the latest information on the status of gene therapy clinical trials, What’s New in Gene Therapy for Ophthalmology? was published in the October issue of Retinal Physician. The final draft was submitted just prior to this important news from Spark Therapeutics providing information about their Phase III clinical trial results.
Principal Investigator Stephen R. Russell, MD, of the Stephen A. Wynn Institute for Vision Research at the University of Iowa, presented Phase III data highlighting the rate, breadth and magnitude of changes following administration of SPK-RPE65 to patients with Leber’s Congenital Amaurosis (LCA), at the (Read more...)